Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Supplementary Figure 3 from Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin Treatment
Home
Publications
Supplementary Figure 3 from Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin Treatment
Supplementary Figure 3 from Dual mTORC1/2 Inhibition Sensitizes Testicular Cancer Models to Cisplatin Treatment
Authors:
XR
Ximena Rosas-Plaza
Ximena Rosas-Plaza
GV
Gerda de Vries
Gerda de Vries
GM
Gert Jan Meersma
Gert Jan Meersma
AS
Albert J.H. Suurmeijer
Albert J.H. Suurmeijer
JG
Jourik A. Gietema
Jourik A. Gietema
MV
Marcel A.T.M. van Vugt
Marcel A.T.M. van Vugt
SJ
Steven de Jong
Steven de Jong
Article Alert
Citation Alert
Add to Library
Cite
Download
Share
Download
Open Access
Publisher website
Google Scholar
3 April 2023
other
Published by
American Association for Cancer Research (AACR)
DOI:
10.1158/1535-7163.22506996.v1
Abstract
MTOR knock down in combination with cisplatin in resistant TC cells
Keywords
INHIBITION SENSITIZES
SUPPLEMENTARY FIGURE
SENSITIZES TESTICULAR
TESTICULAR CANCER
CANCER MODELS
TREATMENT MTOR
CISPLATIN TREATMENT
MTOR KNOCK
FIGURE
DUAL
Related articles
Scroll to top